Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Eating Disorder, Emergency Medicine


Basics


Description


Anorexia Nervosa (AN)
  • Restriction of intake, leading to markedly low body weight for age, height, and/or developmental trajectory
  • Intense fear of gaining weight or becoming fat, or behavior that prevents weight gain
  • Severe body image disturbance, undue influence of body weight and shape on self-evaluation, or denial of seriousness of low body weight
  • Lifetime prevalence: 0.5% of females in US
  • Typical age of onset for AN is bimodal at 13-14 yr and 17-18 yr

Bulimia Nervosa (BN)
  • Recurrent episodes of binge eating characterized by:
    • Eating an unusually large amount of food in a discrete period of time
    • A sense of loss of control over eating during the episode
  • Recurrent inappropriate compensatory behaviors used to prevent weight gain:
    • Self-induced vomiting
    • Misuse of laxatives or enemas
    • Diuretics
    • Diet pills
    • Fasting
    • Excessive exercise
  • Bingeing and compensation occur on average at least once a week for 3 mo
  • Self-evaluation that is excessively influenced by weight or body shape
  • Lifetime prevalence: 2% of females in US
  • Commonly onset in late adolescence or early adulthood.

Binge Eating Disorder (BED)
  • Recurrent episodes of binge eating characterized by:
    • Eating a larger than usual amount of food in a discrete period of time
    • A sense of loss of control over eating during the episode
  • Binge eating episodes associated with 3 or more of the following:
    • Eating much more rapidly than normal
    • Eating until feeling uncomfortably full
    • Eating large amounts of food when not feeling physically hungry
    • Eating alone because of embarrassment about how much one is eating
    • Feeling disgusted with oneself, depressed, or very guilty after overeating
  • Marked distress over binge eating
  • Occurs on average at least once a week for 3 mo
  • No compensatory behavior
  • Lifetime prevalence: 3.5% of females and 2% males in US
  • Onset in late adolescence or early adulthood.

Etiology


  • Twin studies have supported a strong genetic component.
  • Cultural emphasis on thinness as a valued attribute has been implicated
  • Temperament or personality attributes of perfectionism, anxiety, and behavioral rigidity have been described
  • Family conflict or stress is a frequent element
  • Neurochemical (serotonin) and neuroendocrinologic (leptin, HPA axis) abnormalities have been reported
  • Dieting is a frequent immediate precipitant

Diagnosis


Signs and Symptoms


History
  • Rapid or sustained weight loss
  • Typical detailed days eating pattern shows restricting and/or bingeing behavior
  • Purging (vomiting, laxatives, diuretics, enemas)
  • Excessive exercise
  • Dizziness, syncope
  • Bloating (gastroparesis), constipation, abdominal pain
  • Fatigue, lethargy
  • Palpitations
  • Cold intolerance
  • Amenorrhea, loss of libido
  • Family history of eating disorders and obesity
  • Comorbid psychiatric disorder (e.g., mood disorder, substance abuse, personality disorder)

Physical Exam
  • Weight <85% IBW or BMI <17.5 for AN
  • Hypothermia
  • Hypotension, orthostasis
  • Bradycardia, arrhythmia
  • Skin: Dry skin, lanugo (soft downy body hair on chest and arms), carotenoderma
  • Breast atrophy
  • Parotid swelling, submandibular swelling
  • Abnormal dentition
  • Abrasions of dorsum of hand
  • Skin breakdown, poor wound healing
  • Peripheral edema
  • Muscle weakness

Essential Workup


  • History
  • Physical exam
  • Lab testing
  • Nutritional assessment
  • Psychiatric interview:
    • Concurrent psychiatric illness
    • Suicide risk assessment
    • Explore psychosocial context
  • Family evaluation when patient lives with his or her family

Diagnosis Tests & Interpretation


Lab
  • CBC (anemia, leukopenia, thrombocytopenia)
  • Electrolytes, BUN, creatinine, glucose (hyponatremia, hypokalemia, hypoglycemia, dehydration, metabolic alkalosis)
  • Calcium, magnesium, phosphorus, albumin (hypocalcemia, hypomagnesemia, hypophosphatemia, hypoalbuminemia)
  • LFTs (hepatic dysfunction)
  • UA including specific gravity
  • Toxic screen
  • β-hCG
  • Amylase (salivary hyperamylasemia if vomiting, pancreatitis)
  • Lipase (more accurate than amylase in predicting pancreatitis)
  • Consider checking thyroid-stimulating hormone.

Imaging
Specific tests may be useful in making differential diagnoses, e.g., MRI (rule out brain tumor), abdominal CT (rule out obstruction) á
Diagnostic Procedures/Surgery
  • ECG (QTc prolongation, arrhythmia)
  • Consider cardiac echo if substantial weight loss (cardiomyopathy from AN or ipecac)
  • Bone mineral density (osteoporosis)

Differential Diagnosis


  • Medical conditions:
    • GI disease (e.g., Crohns Disease, IBD, celiac disease)
    • Endocrine disorder (e.g., DM, thyroid disorder, adrenal insufficiency)
    • Cancer
  • Psychiatric conditions
    • Borderline personality disorder
    • Mood disorders
    • Obsessive-compulsive disorder
    • Substance abuse

Treatment


Initial Stabilization/Therapy


  • ABCs
  • Careful fluid resuscitation for dehydration to avoid precipitating peripheral or pulmonary edema
  • Replete phosphate and thiamine since both may drop with refeeding
  • Correct hypokalemia, hypomagnesemia, hypocalcemia
  • Correct hypoglycemia
  • Warming blankets for severe hypothermia

Ed Treatment/Procedures


  • Initial workup
  • Medical stabilization
  • Psychiatric consultation (including assessment of suicide risk and psychiatric comorbidities)

Medication


First Line
  • No medication has been demonstrated to be of benefit for AN per se
    • Small trials have suggested possible benefit from atypical antipsychotics, particularly olanzapine 2.5-10 mg PO QD
    • It may be helpful to treat psychiatric comorbidities
  • Only fluoxetine 20-60 mg PO QD has FDA indication for the treatment of BN, though other SSRIs are frequently used. There is also evidence for tricyclic antidepressants as well as topiramate
  • There is evidence for imipramine, sertaline, citalopram/escitalopram, and topiramate for BED

Follow-Up


Disposition


Admission Criteria
  • Medical risk:
    • Extremely low weight (<75% IBW)
    • Rapid weight loss
    • Serum electrolyte imbalance (K <3, glucose <60)
    • Bradycardia <40
    • BP <90/60
    • Orthostasis (>20 bpm or >20 mm Hg/10 mm Hg)
    • Hypothermia <97 ░F
    • Arrhythmia or heart failure
    • Hepatic or renal dysfunction
  • Psychiatric risk:
    • Severe depression, psychosis, or other comorbid psychiatric diagnosis
    • Suicidality
    • Lack of motivation or cooperation with treatment
    • Failure of outpatient treatment
    • Severe impairment in functioning
    • Toxic family environment

Discharge Criteria
  • Medically and psychologically safe enough to be managed on an outpatient basis
  • Multimodal, multidisciplinary team in place to manage medical, nutritional, and psychological issues

Issues for Referral
  • Outpatient treatment requires a team approach composed of a:
    • Psychiatrist and/or psychologist
    • Nutritionist, preferably one who specializes in eating disorders
    • Pediatrician or internist
    • Family therapist
    • Group therapist
    • Dentist
  • Prognosis:
    • AN and BN:
      • 20% chronic course
      • 30% improve
      • 50% recover
    • Mortality rate 5.6% per decade for AN
    • Outcomes improved with early diagnosis and treatment

Follow-Up Recommendations


  • For outpatient treatment the team must establish modest goals and clear parameters, including expected weight gain for anorexic patients and compliance with follow-up appointments.
  • Internist/pediatrician: Monitor vital signs, weight, BMI, electrolytes, and ECG.
  • Nutritionist: Monitor diet, calorie intake, and exercise.
  • Psychotherapy:
    • Cognitive behavioral therapy and interpersonal psychotherapy are the most effective forms of psychotherapy for BN.
    • Cognitive behavioral therapy, family therapy, and psychodynamic therapies are all useful for AN.
    • Family-based treatment is the preferred therapy for teenagers with AN, and it is promising for teenagers with BN as well.
  • Pharmacotherapy:
    • Only indicated within the context of psychotherapy, especially with comorbid psychopathology.
    • No accepted pharmacologic treatment of AN.
      • Case studies suggest that 2nd-generation antipsychotics may be helpful in AN.
      • There is no clear evidence for specific treatment of osteoporosis in AN apart from weight restoration and nutritional calcium supplementation.
    • Antidepressant medications are shown to significantly reduce bingeing and purging behaviors:
      • Fluoxetine is the best studied

Pearls and Pitfalls


  • Eating disorders are associated with high medical risk and risk of suicide; prioritize safety assessment
  • Rapid restoration of nutrition, volume resuscitation, and/or failure to replete vitamins and electrolytes can result in potentially fatal refeeding syndrome
  • Avoid trying to "out-obsess"Ł the obsessional patient
  • Coordinate care with PCP and other members of a multidisciplinary team

Additional Reading


  • Aigner áM, Treasure áJ, Kaye áW, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry.  2011;12:400-443.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
  • American Psychiatric Association (APA). Practice Guidelines for the Treatment of Patients with Eating Disorders. 3rd ed. Washington, DC: 2006, and Guideline Watch (update) August 2012.
  • Mascolo áM, Trent áS, Colwell áC, et al. What the emergency department needs to know when caring for your patients with eating disorders. Int J Eat Disord.  2012;45:977-981.
  • Mitchell áJE, Crow áS. Medical complications of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry.  2006;19(4):438-443.
  • Rosen áDS, American Academy of Pediatrics Committee on Adolescence. Identification and management of eating disorders in children and adolescents. Pediatrics.  2010;126:1240-1253.

Codes


ICD9


  • 307.1 Anorexia nervosa
  • 307.50 Eating disorder, unspecified
  • 307.51 Bulimia nervosa
  • 307.59 Other disorders of eating

ICD10


  • F50.00 Anorexia nervosa, unspecified
  • F50.2 Bulimia nervosa
  • F50.9 Eating disorder, unspecified
  • F50.02 Anorexia nervosa, binge eating/purging type
  • F50.01 Anorexia nervosa, restricting type
  • F50.0 Anorexia nervosa
  • F50.8 Other eating disorders
  • F50 Eating disorders

SNOMED


  • 72366004 Eating disorder (disorder)
  • 56882008 Anorexia nervosa (disorder)
  • 78004001 Bulimia nervosa (disorder)
  • 439960005 binge eating disorder (disorder)
  • 16985007 fasting (finding)
  • 34923007 self-induced vomiting (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer